Compare The Coca-Cola Co K (KO) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
The Coca-Cola Co K vs Novartis AG — how do they compare? The Coca-Cola Co K trades at $82.03 (market cap $353.32B), while Novartis AG trades at $153.88 (market cap $290.25B). The key difference: The Coca-Cola Co K is the larger of the two by market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| KO | NVS | |
|---|---|---|
Market Cap | $353.32B | $290.25B |
Volume | 14,630,257 | — |
Sector | Consumer Staples | Health |
52-Week High | $84.92 | $168.62 |
52-Week Low | $65.67 | $113.50 |
Enterprise Value | $383.39B | $330.27B |
Dividend Yield | 2.58% | 3.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Coca-Cola (KO) trades at $81.97, up 0.5% today, with a bullish analyst consensus and strong fundamentals. The stock shows consistent earnings beats, with Q1 2026 EPS of $0.86 beating expectations, and robust profitability metrics including a 27.8% net income margin. Technical indicators are mixed, with moving averages bullish but oscillators neutral. Recent news highlights institutional buying and stable demand trends, though regional divergences exist.
The outlook remains positive with a consensus price target of $90.67, offering ~11% upside. Risks include macroeconomic headwinds and competitive pressures, but the company's dividend history and strong cash flow support long-term stability. Earnings growth and institutional confidence are key catalysts for further appreciation.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About The Coca-Cola Co K
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
